Health In Tech Q2 FY26 net loss widens to $2.5 million; revenue falls to $8.1 million
Reuters2026/08/13 20:37- Health In Tech Q2 revenue fell to $8.1 million from $9.3 million a year earlier.
- Net results swung to a $2.5 million loss, or $(0.04) per diluted share, from $0.6 million profit, or $0.01.
- Adjusted EBITDA (non-GAAP) turned to a $1.3 million loss from $1.6 million profit.
- Contracted revenue totaled $32.3 million as of June 30; pipeline revenue reached $66.3 million as of July 31.
- CEO Tim Johnson cited investments in sales, marketing, and talent; HitRix marketplace platform remains slated for a second-half launch.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Goldman Sachs remains bullish on the South Korean stock market: Driven by the AI memory boom, with a potential upside of up to 80%.
Goldman Sachs strategist Timothy Moe maintains his bullish target on the South Korean stock market, believing that investors are underestimating how long the benefits of artificial intelligence (AI) will last for the country's memory chip manufacturers.
Oranjebtc cancels 25 million treasury shares without capital reduction
The Last Time Treasury Yields Hit 6%, Bitcoin Didn't Exist — What Happens If They Get There Again?
Crypto prices
More
